RankinidineCAS# 106466-66-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 106466-66-4 | SDF | Download SDF |
| PubChem ID | 6439112 | Appearance | Powder |
| Formula | C20H24N2O3 | M.Wt | 340.4 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (7Z)-7-ethylidene-1'-methoxyspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3'-indole]-2'-one | ||
| SMILES | CC=C1CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC | ||
| Standard InChIKey | ZXRGGMATGWCUBP-KGVSQERTSA-N | ||
| Standard InChI | InChI=1S/C20H24N2O3/c1-3-12-10-21-16-9-20(18-8-13(12)14(16)11-25-18)15-6-4-5-7-17(15)22(24-2)19(20)23/h3-7,13-14,16,18,21H,8-11H2,1-2H3/b12-3+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Rankinidine Dilution Calculator
Rankinidine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9377 mL | 14.6886 mL | 29.3772 mL | 58.7544 mL | 73.443 mL |
| 5 mM | 0.5875 mL | 2.9377 mL | 5.8754 mL | 11.7509 mL | 14.6886 mL |
| 10 mM | 0.2938 mL | 1.4689 mL | 2.9377 mL | 5.8754 mL | 7.3443 mL |
| 50 mM | 0.0588 mL | 0.2938 mL | 0.5875 mL | 1.1751 mL | 1.4689 mL |
| 100 mM | 0.0294 mL | 0.1469 mL | 0.2938 mL | 0.5875 mL | 0.7344 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Methyl indole-3-acetate
Catalog No.:BCX0475
CAS No.:1912-33-0
- Galanal B
Catalog No.:BCX0474
CAS No.:104113-52-2
- Labda-8(17),12E,14-trien-16,15-olide
Catalog No.:BCX0473
CAS No.:917078-10-5
- Mulberrofuran V
Catalog No.:BCX0472
CAS No.:174423-49-5
- 6'-O-p-Hydroxybenzoylgastrodin
Catalog No.:BCX0471
CAS No.:1551525-70-2
- 15-Hydroxylabda-8(17),12E-dien-16-al
Catalog No.:BCX0470
CAS No.:283614-59-5
- Sanggenol F
Catalog No.:BCX0469
CAS No.:202526-51-0
- Moracin B
Catalog No.:BCX0468
CAS No.:67259-16-9
- Procumboside A
Catalog No.:BCX0467
CAS No.:850894-16-5
- Zataroside A
Catalog No.:BCX0466
CAS No.:95645-53-7
- 6β-Hydroxy-7-epi-α-cyperone
Catalog No.:BCX0465
CAS No.:6851-55-4
- Alpinenone
Catalog No.:BCX0464
CAS No.:103425-23-6
- Sinapyl alcohol
Catalog No.:BCX0477
CAS No.:537-33-7
- Gypenoside LXXV
Catalog No.:BCX0478
CAS No.:110261-98-8
- Indole-3-acetic acid β-D-glucopyranosyl ester
Catalog No.:BCX0479
CAS No.:19817-95-9
- Schisanhenol B
Catalog No.:BCX0480
CAS No.:102681-52-7
- Schisandrathera D
Catalog No.:BCX0481
CAS No.:2694046-04-1
- Dencichine
Catalog No.:BCX0482
CAS No.:5302-45-4
- Deoxylimonin
Catalog No.:BCX0483
CAS No.:989-23-1
- 5-Methoxydadahol A
Catalog No.:BCX0484
CAS No.:2410566-84-4
- 4-(3-Hydroxydecyl)phenol
Catalog No.:BCX0485
CAS No.:1465124-36-0
- Oxyphyllone D
Catalog No.:BCX0486
CAS No.:1190094-25-7
- Rugulolide A
Catalog No.:BCX0487
CAS No.:3002032-70-1
- Rugulolide B
Catalog No.:BCX0488
CAS No.:3002032-71-2
A high-resolution mass spectrometric approach to a qualitative and quantitative comparative metabolism of the humantenine-type alkaloid rankinidine.[Pubmed:35344234]
Rapid Commun Mass Spectrom. 2022 Jun 30;36(12):e9302.
RATIONALE: Rankinidine belongs to the humantenine-type alkaloids isolated from Gelsemium. Currently, the mechanism behind the toxicity differences of Rankinidine has not been explained. In this study, our purpose was to elucidate the major in vitro metabolic pathways of Rankinidine and to compare the formation of metabolites of Rankinidine in human (HLMs), rat (RLMs), goat (GLMs) and pig (PLMs) liver microsomes. METHODS: This is the first study to compare the in vitro metabolism of Rankinidine with high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/QTOF). The MS/MS data and LC/MS peak area acquired in positive ion mode were used to analyze metabolite structures and compare metabolism. RESULTS: We identified 11 metabolites (M1-M11) in total and found five main metabolic pathways, consisting of demethylation (M1), reduction (M2), oxidation at different positions (M3-M5), oxidation and reduction (M6-M10) and demethylation and oxidation (M11). The metabolism of Rankinidine has qualitative and quantitative species-specific differences in vitro. In PLMs and GLMs, the main metabolic pathway of Rankinidine was oxidation. Notably, among the four species, the oxidation ability of Rankinidine was highest in pigs and goats, and the demethylation and reduction abilities of Rankinidine were highest in humans and rats. CONCLUSIONS: The interspecific metabolic differences of Rankinidine in HLMs, PLMs, GLMs and RLMs were compared and studied for the first time using LC/QTOF. These findings will certainly support future studies of Rankinidine metabolism in vivo and will contribute to elucidating the cause of species-specific differences behind Gelsemium toxicity.
Rankinidine, a new indole alkaloid from Gelsemium rankinii.[Pubmed:3819733]
J Nat Prod. 1986 Sep-Oct;49(5):806-8.
A new oxindole alkaloid, Rankinidine (1), has been isolated from the MeOH extract of the stem of Gelsemium rankinii. Its structure was elucidated by comparison with an analog, humantenirine (3), which also occurred in this plant.
